These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12058238)

  • 1. Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab.
    Hongeng S; Tardtong P; Worapongpaiboon S; Ungkanont A; Jootar S
    Bone Marrow Transplant; 2002 May; 29(10):871-2. PubMed ID: 12058238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for the treatment of post-bone marrow transplantation refractory hemolytic anemia in a child with Omenn's syndrome.
    Silvana B; Antonella LM; Basilia P; Trombetta D; Saija A; Salpietro C
    Pediatr Transplant; 2007 Aug; 11(5):552-6. PubMed ID: 17631027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation.
    Drobyski WR; Potluri J; Sauer D; Gottschall JL
    Bone Marrow Transplant; 1996 Jun; 17(6):1093-9. PubMed ID: 8807120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation.
    Horn B; Viele M; Mentzer W; Mogck N; DeSantes K; Cowan M
    Bone Marrow Transplant; 1999 Nov; 24(9):1009-13. PubMed ID: 10556961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases.
    O'Brien TA; Eastlund T; Peters C; Neglia JP; Defor T; Ramsay NK; Scott Baker K
    Br J Haematol; 2004 Oct; 127(1):67-75. PubMed ID: 15384979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rituximab instead of splenectomy in 4 children with chronic or refractory autoimmune haemolytic anaemia].
    van Daalen ST; van Dijken PJ; Tamminga RY; Brons PP
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2350-4. PubMed ID: 16261716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous peripheral blood stem cell transplantation and anti-B-cell directed immunotherapy for refractory auto-immune haemolytic anaemia.
    Seeliger S; Baumann M; Mohr M; Jürgens H; Frosch M; Vormoor J
    Eur J Pediatr; 2001 Aug; 160(8):492-6. PubMed ID: 11548187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
    Perrotta S; Locatelli F; La Manna A; Cennamo L; De Stefano P; Nobili B
    Br J Haematol; 2002 Feb; 116(2):465-7. PubMed ID: 11841453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia.
    De Lord C; Marsh JC; Smith JG; Singer CR; Gordon-Smith EC
    Bone Marrow Transplant; 1996 Jul; 18(1):237-9. PubMed ID: 8832026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant.
    Chen FE; Owen I; Savage D; Roberts I; Apperley J; Goldman JM; Laffan M
    Bone Marrow Transplant; 1997 Mar; 19(5):491-5. PubMed ID: 9052917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of refractory warm autoimmune hemolytic anemia treated with plasmapheresis and rituximab.
    Aglieco F; Manickaratnam S; Bona R; Kaplan AA
    Ther Apher Dial; 2008 Apr; 12(2):185-9. PubMed ID: 18387171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
    Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
    Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions.
    Cwynarski K; Goulding R; Pocock C; Dazzi F; Craddock C; Kaeda J; Olavarria E; Kanfer E; Apperley J; Lawler M; Goldman JM
    Bone Marrow Transplant; 2001 Sep; 28(6):581-6. PubMed ID: 11607771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
    Radhi M; Rumelhart S; Tatman D; Goldman F
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for refractory childhood autoimmune hemolytic anemia.
    Motto DG; Williams JA; Boxer LA
    Isr Med Assoc J; 2002 Nov; 4(11):1006-8. PubMed ID: 12489491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
    D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
    Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with rituximab for autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus and monoclonal gammopathy in a post-nonmyeloablative stem cell transplant patient.
    Endo T; Nakao S; Koizumi K; Nishio M; Fujimoto K; Sakai T; Kumano K; Obara M; Koike T
    Ann Hematol; 2004 Feb; 83(2):114-6. PubMed ID: 14513283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood refractory autoimmune haemolytic anaemia: is there a role for anti-CD20 therapy (rituximab)?
    McMahon C; Babu L; Hodgson A; Hayat A; Connell NO; Smith OP
    Br J Haematol; 2002 May; 117(2):480-3. PubMed ID: 11972537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.